Sonova Appoints Arnd Kaldowski as New CEO

To further support the long-term continuity in the leadership of the company and to secure his extensive industry knowhow, the Board of Directors will propose Braunschweiler for election as a member of the Board of Directors of Sonova at the Annual General Shareholders’ Meeting in June 2018. In his...

Full description

Saved in:
Bibliographic Details
Published inThe Hearing Review (Online)
Format Newspaper Article
LanguageEnglish
Published Los Angeles Anthem Media Group 01.09.2017
Subjects
Appointments & personnel changes
Chief executive officers
Leadership
Webcasting
Online AccessGet full text

Cover

More Information
Summary:To further support the long-term continuity in the leadership of the company and to secure his extensive industry knowhow, the Board of Directors will propose Braunschweiler for election as a member of the Board of Directors of Sonova at the Annual General Shareholders’ Meeting in June 2018. In his most recent role as Group Executive Diagnostics Platform and President, Beckman Coulter Diagnostics at Danaher Corporation, Kaldowski had overall revenue responsibility of USD $5.5 billion globally, including direct reporting of the operating companies Radiometer, Leica Biosystems, and Cepheid, and including the heads of HR, legal, finance, business development (M&A), clinical affairs, regulatory, and quality. Before joining Danaher, Kaldowski was SVP, Point-of-Care Solutions at Siemens Medical, following his previous assignments as Investment Director of Atila Ventures and as Manager with the Boston Consulting Group.
Bibliography:SourceType-Other Sources-1
ObjectType-News-1
content type line 21